These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

209 related items for PubMed ID: 7995734

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [NSAID therapy. Gastrointestinal risks of classic NSAID are underestimated].
    MMW Fortschr Med; 2010 May 20; 152(20):46-7. PubMed ID: 20552882
    [No Abstract] [Full Text] [Related]

  • 4. Anti-inflammatory efficacy versus gastrointestinal safety: a dilemma resolved? Introduction.
    Bach GL.
    Scand J Rheumatol Suppl; 1992 May 20; 96():5-6. PubMed ID: 1439625
    [No Abstract] [Full Text] [Related]

  • 5. A regional audit of the use of COX-2 selective non-steroidal anti-inflammatory drugs (NSAIDs) in rheumatology clinics in the West Midlands, in relation to NICE guidelines.
    Price-Forbes AN, Callaghan R, Allen ME, Rowe IF.
    Rheumatology (Oxford); 2005 Jul 20; 44(7):921-4. PubMed ID: 15827035
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Systematic review of celecoxib for osteoarthritis and rheumatoid arthritis. Celecoxib's relative gastrointestinal safety is overstated.
    Metcalfe S, Dougherty S, McNee W.
    BMJ; 2003 Feb 08; 326(7384):334; author reply 334. PubMed ID: 12575714
    [No Abstract] [Full Text] [Related]

  • 13. Keeping patients with arthritis out of the hospital.
    Spiegel M.
    Manag Care Interface; 1998 Jun 08; 11(6):81-5. PubMed ID: 10181565
    [Abstract] [Full Text] [Related]

  • 14. COX-2 inhibitors.
    Brooks PM, Day RO.
    Med J Aust; 2000 Oct 16; 173(8):433-6. PubMed ID: 11090038
    [Abstract] [Full Text] [Related]

  • 15. Results from a patient survey to assess gastrointestinal burden of non-steroidal anti-inflammatory drug therapy contrasted with a review of data from EVA to determine satisfaction with rofecoxib.
    Steinfeld S, Bjørke PA.
    Rheumatology (Oxford); 2002 Apr 16; 41 Supp 1():23-7; discussion 35-42. PubMed ID: 12173277
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Drug switching patterns among patients with rheumatoid arthritis and osteoarthritis using COX-2 specific inhibitors and non-specific NSAIDs.
    Zhao SZ, Wentworth C, Burke TA, Makuch RW.
    Pharmacoepidemiol Drug Saf; 2004 May 16; 13(5):277-87. PubMed ID: 15133778
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.